Financial Obligation (Form 8-K)

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

As previously disclosed, on April 21, 2026, TuHURA Biosciences, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with Parkview Holdings One LLC, as lender. The Loan Agreement provides for a revolving credit facility that matures on April 21, 2031, with a maximum amount of loan availability of $50 million. On June 30, 2026, the Company received and borrowed an additional draw under the revolving credit facility in the amount $1,900,000 and expects to use the funds for general corporate purposes.

The description of the Loan Agreement contained herein does not purport to be complete and is qualified in its entirety by reference to the complete text of the Loan Agreement, a copy of which was filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed on April 22, 2026.